Showing results (901-910 of 928) with videos related to

Sort By:
Pageof 93
Chest|March 8, 2022
Pulmonary and Critical Care Considerations for e-Cigarette, or Vaping, Product Use-Associated Lung InjuryDon Hayes, Amy Board, Carolyn S Calfee, et al.
Tropical Medicine and Health|August 2, 2025
Screening for visceral leishmaniasis in humans and animals in LaosTamalee Roberts, Anousone Douangnouvong, Matthew T Robinson, et al.
Cell|October 7, 2017
Cohesin Loss Eliminates All Loop DomainsSuhas S P Rao, Su-Chen Huang, Brian Glenn St Hilaire, et al.
NPJ Vaccines|January 17, 2026
Association between COVID-19 vaccine efficacy and epidemic force of infectionJing Xu, M Elizabeth Halloran, Mia Moore, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 12, 2026
Limited effects of dietary nitrate supplementation with resistance training on skeletal muscle and vascular outcomes and in middle-aged and older adultsMason C McIntosh, Breanna J Mueller, Dakota R Tiede, et al.
BMJ Open|September 4, 2025
Influenza and respiratory syncytial virus dynamics in Lao PDR during the COVID-19 pandemic: a hospital-based surveillance studyKoukeo Phommasone, Danoy Chommanam, Nathaniel C Christy, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 28, 2013
Risk for transmission of Naegleria fowleri from solid organ transplantationS L Roy, R Metzger, J G Chen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 25, 2024
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine TrialNigel Garrett, One Dintwe, Cynthia L Monaco, et al.
The Lancet. HIV|May 1, 2024
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trialIan Frank, Shuying S Li, Nicole Grunenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2026
Circulating PEG-indoleamine 2,3-dioxygenase ameliorates diverse inflammatory diseases without toxicity or compromising immunocompetenceJennifer A Simonovich, Ryan A Clark, Alexander J Kwiatkowski, et al.
Pageof 93